Pfizer''s COVID cash pile opens opportunities for deals

06:08pm, Monday, 07'th Feb 2022 Investing.com
https://www.investing.com/news/stock-market-news/pfizers-covid-cash-pile-opens-opportunities-for-deals-2758633

Pfizer''s COVID cash pile opens opportunities for deals

06:03pm, Monday, 07'th Feb 2022 Reuters
Investors on Tuesday hope to learn Pfizer Inc''s plans for what could be a once-in-a-generation cash infusion from COVID-19 treatments and vaccines in 2022, with some looking for the drugmaker to spend on deals.
Vaccine-themed names are rising in popularity with pet owners calling their puppies Pfizer and Zeneca
Pfizer (NYSE:PFE) is scheduled to announce Q4 earnings results on Tuesday, February 8th, before market open.The consensus EPS Estimate is $0.87 (+107.1% Y/Y) and the consensus…
The company is not only selling tens of billions of dollars worth of its Covid-19 vaccine, it has the leading antiviral treatment for the coronavirus.

Key Events This Week: All Eyes On The CPI

02:54pm, Monday, 07'th Feb 2022 Zero Hedge
Key Events This Week: All Eyes On The CPI After what DB''s Jim Reid describes as "a week for the ages" this week should be calmer until of course US CPI comes along on Thursday. As the Deutsche strategist notes, in his look back at a hell of a week, what made last week so fascinating was the rare interplay between macro and micro. Not only did the rates world shake and reverberate (2yr bunds +35.9bps and the worse week since 2008), but on successive days we saw the biggest market cap fall in history for any company (Meta), followed by the biggest rise ever (Amazon). We have 83 S&P 500 companies reporting this week but no Goliath sized ones, so it''ll be a more normal week for earnings. The macro and micro last week was enough to push the Russian/Ukraine tensions into the background but they are clearly still there so we have to watch out for that as well. Over the weekend ECB governor Knott (a hawk) became the first ECB official to confirm what we reported last week, when he endorsed a 2022 hike by suggesting that he expects a hike around Q4 and another in Spring 2023, and that they are most likely to be in 25bps increments.

Pfizer Earnings: What to Look For From PFE

02:12pm, Monday, 07'th Feb 2022 Investopedia
Pfizer (PFE) reports Q4 earnings in the morning on Feb. 8. Will demand for its COVID-19 vaccine remain strong enough to keep profits and revenue rising?
Monday''s top analyst upgrades and downgrades included Bill.com, Cigna, ConocoPhillips, Estee Lauder, Fortinet, Microchip Technology, Pfizer, Skyworks Solutions, Snap, Snowflake, VICI Properties and Wipro.
MANILA, Philippines Nearly a year after the Philippines rolled out its COVID-19 vaccination drive, the government on Monday, February 7, began vaccinating children aged 5 to 11 in select areas in the country. Pfizer vaccine is being used for the jabs as this is the only shot that has received emergency use approval for kids aged 5 to 11 years from the Philippines Food and Drug Administration. The Pfizer vaccine for them has a lower dosage and lower concentration than those given to youths aged 12 to 17. The country began vaccinating 12- to 17-year-olds in October 2021. In Metro Manila, there were at least six sites that started their vaccination on Monday. These were the Philippine Heart Center, the Philippine Childrens Medical Center, National Childrens Hospital, Manila Zoo, SM North Edsa (Skydome), and the Fil Oil Gym in San Juan City. In Cavite, the vaccination drive was also launched at the Southern Tagalog Regional Hospital in Bacoor. The government is aiming to vaccinate some 15.5 million children aged 5 to 11 in the country.

Can the FDA Get It Right on Covid Vaccines for Young Kids?

01:00pm, Monday, 07'th Feb 2022 The Washington Post
Pfizers shot for children younger than 5 could be given emergency authorization later this month. Public health officials will need to clearly and simply explain why thats needed.
Futures Tread Water Amid Peripheral Bond Rout As Key CPI Print Looms U.S. index futures swung around in a volatile, illiquid overnight session, and at last check were flat despite traders'' concerns about growing fireworks in the European bond market where Italian and Greek bond plunged amid fears of ECB rate hikes as soon as October, while waiting for Thursday''s key CPI data and further corporate earnings. S&P 500 futures were up 2 points or 0.05%, Nasdaq futures were up 26 points or 0.18% and Dow futures were up fractionally as markets now expect more than five quarter-point Federal Reserve interest-rate hikes in 2022 to keep inflation on check following a strong U.S. jobs report. Treasury yields and the dollar were stable, while the euro snapped a six-day strengthening run. WTI crude fell after last week''s rally. Chinese shares climbed on their return from a weeklong holiday. Bitcoin extended its recovery surge. In the premarket, Peloton was in focus, soaring 27% on reports it''s evaluating interest from potential suitors including Amazon and Nike.

Pasig City COVID-19 vax for kids aged 5-11 delayed

12:46pm, Monday, 07'th Feb 2022 Manila Bulletin News
Pasig City was unable to join in the pilot launch of the COVID-19 vaccination for minors aged five to 11 years old on Monday, Feb. 7. According to the city government, the shipment of Pfizer vaccines for children belonging to the said age group had not been delivered as of Sunday, Feb. 6. New vaccination sites will be opened in Pasig City to assist in facilitating the pediatric vaccination once the city receives the shipment of vaccines. The city has not yet announced when it would begin vaccinating minors in the lower age bracket. However, residents of Pasig wanting to have their children ages five to 17 can register them through Pasig City’s online vaccine registration and contact tracing facility which can be found here: https://pasigpass.pasigcity.gov.ph/ The pediatric vaccination for minors in the five to 11 age bracket officially began on Monday, Feb. 7, in Manila, Quezon City, Makati City, Pasay City, San Juan City, Paranaque City, Muntinlupa City, Caloocan City, Marikina City, and Valenzuela City.

Sahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SA

12:19pm, Monday, 07'th Feb 2022 Eyewitness News
South African Health Products Regulatory Authority (Sahpra) spokesperson, Yuven Gounden, said that the regulator had received all the required data on the Sinopharm jab to enable full registration.

Covid-19 Pill Competing With Pfizer''s Looks for Quick Approval in Japan

11:10am, Monday, 07'th Feb 2022 The Wall Street Journal
Japanese drugmaker Shionogi says its pill offers advantages over Paxlovid because it is taken once a day without any additional medication.

Covid-19 Pill Competing With Pfizers Looks for Quick Approval in Japan

11:10am, Monday, 07'th Feb 2022 The Wall Street Journal
Japanese drugmaker Shionogi says its pill offers advantages over Paxlovid because it is taken once a day without any additional medication.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE